Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colon Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03113318
What this trial is testing

Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer

Who this might be right for
Lung NeoplasmsNeoplasm MetastasisColorectal Cancer
Rigshospitalet, Denmark 200
Not applicableWithdrawnNCT06221423
What this trial is testing

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Fudan University
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Early research (Phase 1)Study completedNCT00353262
What this trial is testing

Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 36
Post-approval studies (Phase 4)Ended earlyNCT00114946
What this trial is testing

Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc. 800
Early research (Phase 1)Ended earlyNCT02559024
What this trial is testing

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Providence Health & Services 4
Testing effectiveness (Phase 2)Ended earlyNCT00908024
What this trial is testing

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerNeoplasm Metastasis
Bristol-Myers Squibb 54
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Large-scale testing (Phase 3)Looking for participantsNCT05768503
What this trial is testing

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Who this might be right for
Metastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University 176
Large-scale testing (Phase 3)UnknownNCT02402972
What this trial is testing

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Who this might be right for
Colorectal CancerMetastasis
Xu jianmin 700
Testing effectiveness (Phase 2)Study completedNCT03475004
What this trial is testing

Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Colorado, Denver 53
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694936
What this trial is testing

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446387
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502014
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)mCRC
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513221
What this trial is testing

A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608044
What this trial is testing

Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Agenus Inc. 234
Testing effectiveness (Phase 2)Looking for participantsNCT07255664
What this trial is testing

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Who this might be right for
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
CuraCell TX AB 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04294264
What this trial is testing

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal Carcinoma+3 more
Rutgers, The State University of New Jersey 50
Next Page